Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 162, Issue , 2003, Pages 115-132

  Kopp, Reinhard ^a   Rothbauer, Elisabeth ^a   Ruge, Maximilian ^a   Arnholdt, Hans ^a   Spranger, Joachim ^a   Muders, M ^a   Pfeiffer, Doris G ^a   Schildberg, Friedrich Wilhelm ^a   Pfeiffer, Andreas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; PROTEIN TYROSINE KINASE;

BIOLOGICAL MODEL; CELL CULTURE; CELL SURVIVAL; CLINICAL TRIAL; COLON; DISEASE COURSE; GASTROINTESTINAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MUCOSA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TIME;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CLINICAL TRIALS; COLON; DISEASE PROGRESSION; ENZYME INHIBITORS; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; MODELS, BIOLOGICAL; MUCOUS MEMBRANE; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0042783111     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-59349-9_10     Document Type: Review

References (65)